Wells Fargo’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
Wells Fargo's CODX Position: Q3 2026 in Review
Wells Fargo held its Co-Diagnostics (CODX) position steady in Q3 2026 at 81 shares worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #6675.
Wells Fargo first reported a position in CODX in Q1 2020 and has held it in 27 quarters since. The position peaked at $2.54M in Q1 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q3 2026.
- Wells Fargo held 81 shares of Co-Diagnostics worth $87 as of Q3 2026.
- Wells Fargo left its Co-Diagnostics share count unchanged in Q3 2026.
- Co-Diagnostics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #6675 holding.
- Wells Fargo first reported a position in Co-Diagnostics in Q1 2020 and has held it in 27 quarters since.
- Wells Fargo's Co-Diagnostics position peaked at $2.54M in Q1 2021.
- 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.